UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): 10/27/2008
QUANTUM CORPORATION
(Exact name of registrant as specified in its charter)
Commission File Number: 1-13449
|
Delaware
|
|
94-2665054
|
|
(State or other jurisdiction of
|
|
(IRS Employer
|
|
incorporation)
|
|
Identification No.)
|
1650 Technology Drive
Suite 800
San Jose, CA 95110
(Address of principal executive offices, including zip code)
408-944-4000
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events
On October 27, 2008, Quantum was notified by the New York Stock Exchange ("NYSE") that it was not in compliance with the NYSE's continued listing standard requiring that stocks trade at a minimum average closing price of $1.00 for 30 consecutive trading days. Under NYSE rules, Quantum must inform the NYSE by November 10, 2008, of its intent to cure the average stock price deficiency, and it intends to do so. Quantum has until April 27, 2009 to comply with the listing standard or be subject to suspension and delisting procedures. Quantum's stock will continue to be listed on the NYSE during the six-month cure period, subject to compliance with other NYSE continued listing requirements. A copy of Quantum's press release is attached as Exhibit 99.1 hereto and incorporated by reference.This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing."
Signature(s)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
|
|
|
QUANTUM CORPORATION
|
| |
| |
|
Date: October 31, 2008
|
|
|
|
By:
|
|
/s/ Shawn D. Hall
|
| |
|
|
|
|
|
|
|
Shawn D. Hall
|
| |
|
|
|
|
|
|
|
Vice President, General Counsel and Secretary
|
| |
| |
Exhibit Index
|
Exhibit No.
|
|
Description
|
|
EX-99.1
|
|
Press Release dated October 31, 2008
|